Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice - PubMed (original) (raw)
Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice
A Cerwenka et al. Immunity. 2000 Jun.
Free article
Abstract
Here we describe a family of GPI-anchored cell surface proteins that function as ligands for the mouse activating NKG2D receptor. These molecules are encoded by the retinoic acid early inducible (RAE-1) and H60 minor histocompatibility antigen genes on mouse chromosome 10 and show weak homology with MHC class I. Expression of the NKG2D ligands is low or absent on normal, adult tissues; however, they are constitutively expressed on some tumors and upregulated by retinoic acid. Ectopic expression of RAE-1 and H60 confers target susceptibility to NK cell attack. These studies identify a family of ligands for the activating NKG2D receptor on NK and T cells, which may play an important role in innate and adaptive immunity.
Similar articles
- A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.
Diefenbach A, Hsia JK, Hsiung MY, Raulet DH. Diefenbach A, et al. Eur J Immunol. 2003 Feb;33(2):381-91. doi: 10.1002/immu.200310012. Eur J Immunol. 2003. PMID: 12645935 - Ligands for murine NKG2D display heterogeneous binding behavior.
Carayannopoulos LN, Naidenko OV, Kinder J, Ho EL, Fremont DH, Yokoyama W. Carayannopoulos LN, et al. Eur J Immunol. 2002 Mar;32(3):597-605. doi: 10.1002/1521-4141(200203)32:3<597::aid-immu597>3.3.co;2-5. Eur J Immunol. 2002. PMID: 11857333 - Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity.
Diefenbach A, Jensen ER, Jamieson AM, Raulet DH. Diefenbach A, et al. Nature. 2001 Sep 13;413(6852):165-71. doi: 10.1038/35093109. Nature. 2001. PMID: 11557981 Free PMC article. - Strategies for target cell recognition by natural killer cells.
Diefenbach A, Raulet DH. Diefenbach A, et al. Immunol Rev. 2001 Jun;181:170-84. doi: 10.1034/j.1600-065x.2001.1810114.x. Immunol Rev. 2001. PMID: 11513138 Review. - Ligands for natural killer cell receptors: redundancy or specificity.
Cerwenka A, Lanier LL. Cerwenka A, et al. Immunol Rev. 2001 Jun;181:158-69. doi: 10.1034/j.1600-065x.2001.1810113.x. Immunol Rev. 2001. PMID: 11513137 Review.
Cited by
- Phytochemicals as Immunomodulatory Molecules in Cancer Therapeutics.
Paudel S, Mishra N, Agarwal R. Paudel S, et al. Pharmaceuticals (Basel). 2023 Nov 26;16(12):1652. doi: 10.3390/ph16121652. Pharmaceuticals (Basel). 2023. PMID: 38139779 Free PMC article. Review. - Therapeutic avenues for γδ T cells in cancer.
Costa GP, Mensurado S, Silva-Santos B. Costa GP, et al. J Immunother Cancer. 2023 Nov 24;11(11):e007955. doi: 10.1136/jitc-2023-007955. J Immunother Cancer. 2023. PMID: 38007241 Free PMC article. Review. - Porcine UL-16 Binding Protein 1 Is Not a Functional Ligand for the Human Natural Killer Cell Activating Receptor NKG2D.
Lopez KJ, Spence JP, Li W, Zhang W, Wei B, Cross-Najafi AA, Butler JR, Cooper DKC, Ekser B, Li P. Lopez KJ, et al. Cells. 2023 Nov 7;12(22):2587. doi: 10.3390/cells12222587. Cells. 2023. PMID: 37998322 Free PMC article. - IL-17a-producing γδT cells and NKG2D signaling mediate bacterial endotoxin-induced neonatal lung injury: implications for bronchopulmonary dysplasia.
Cui TX, Brady AE, Zhang YJ, Anderson C, Popova AP. Cui TX, et al. Front Immunol. 2023 Sep 8;14:1156842. doi: 10.3389/fimmu.2023.1156842. eCollection 2023. Front Immunol. 2023. PMID: 37744375 Free PMC article. - Understanding NK cell biology for harnessing NK cell therapies: targeting cancer and beyond.
Shin E, Bak SH, Park T, Kim JW, Yoon SR, Jung H, Noh JY. Shin E, et al. Front Immunol. 2023 Jul 18;14:1192907. doi: 10.3389/fimmu.2023.1192907. eCollection 2023. Front Immunol. 2023. PMID: 37539051 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous